1. The JmjN domain of Jhd2 is important for its protein stability, and the plant homeodomain (PHD) finger mediates its chromatin association independent of H3K4 methylation. Huang F, Chandrasekharan MB, Chen YC, Bhaskara S, Hiebert SW, Sun ZW (2010) J Biol Chem 285(32): 24548-61
    › Primary publication · 20538609 (PubMed) · PMC2915691 (PubMed Central)
  2. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia. Engel ME, Hiebert SW (2010) Cancer Treat Res : 127-47
    › Primary publication · 20306249 (PubMed)
  3. Myeloid translocation gene 16 (MTG16) interacts with Notch transcription complex components to integrate Notch signaling in hematopoietic cell fate specification. Engel ME, Nguyen HN, Mariotti J, Hunt A, Hiebert SW (2010) Mol Cell Biol 30(7): 1852-63
    › Primary publication · 20123979 (PubMed) · PMC2838074 (PubMed Central)
  4. Hdac3 is essential for the maintenance of chromatin structure and genome stability. Bhaskara S, Knutson SK, Jiang G, Chandrasekharan MB, Wilson AJ, Zheng S, Yenamandra A, Locke K, Yuan JL, Bonine-Summers AR, Wells CE, Kaiser JF, Washington MK, Zhao Z, Wagner FF, Sun ZW, Xia F, Holson EB, Khabele D, Hiebert SW (2010) Cancer Cell 18(5): 436-47
    › Primary publication · 21075309 (PubMed) · PMC3004468 (PubMed Central)
  5. Anticancer therapy SMRT-ens up: targeting the BCL6-SMRT interaction in B cell lymphoma. Compton LA, Hiebert SW (2010) Cancer Cell 17(4): 315-6
    › Primary publication · 20385356 (PubMed)
  6. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. Knutson SK, Chyla BJ, Amann JM, Bhaskara S, Huppert SS, Hiebert SW (2008) EMBO J 27(7): 1017-28
    › Primary publication · 18354499 (PubMed) · PMC2323257 (PubMed Central)
  7. Deletion of Mtg16, a target of t(16;21), alters hematopoietic progenitor cell proliferation and lineage allocation. Chyla BJ, Moreno-Miralles I, Steapleton MA, Thompson MA, Bhaskara S, Engel M, Hiebert SW (2008) Mol Cell Biol 28(20): 6234-47
    › Primary publication · 18710942 (PubMed) · PMC2577421 (PubMed Central)
  8. Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. Bhaskara S, Chyla BJ, Amann JM, Knutson SK, Cortez D, Sun ZW, Hiebert SW (2008) Mol Cell 30(1): 61-72
    › Primary publication · 18406327 (PubMed) · PMC2373760 (PubMed Central)
  9. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Linggi B, Müller-Tidow C, van de Locht L, Hu M, Nip J, Serve H, Berdel WE, van der Reijden B, Quelle DE, Rowley JD, Cleveland J, Jansen JH, Pandolfi PP, Hiebert SW (2002) Nat Med 8(7): 743-50
    › Primary publication · 12091906 (PubMed)
  10. Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins. Barseguian K, Lutterbach B, Hiebert SW, Nickerson J, Lian JB, Stein JL, van Wijnen AJ, Stein GS (2002) Proc Natl Acad Sci U S A 99(24): 15434-9
    › Primary publication · 12427969 (PubMed) · PMC137734 (PubMed Central)